JP3064077B2 - Composite implant components - Google Patents

Composite implant components

Info

Publication number
JP3064077B2
JP3064077B2 JP3343435A JP34343591A JP3064077B2 JP 3064077 B2 JP3064077 B2 JP 3064077B2 JP 3343435 A JP3343435 A JP 3343435A JP 34343591 A JP34343591 A JP 34343591A JP 3064077 B2 JP3064077 B2 JP 3064077B2
Authority
JP
Japan
Prior art keywords
zirconia
titanium
glass
composite implant
strength
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP3343435A
Other languages
Japanese (ja)
Other versions
JPH05168693A (en
Inventor
謙三 牧野内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyocera Corp
Original Assignee
Kyocera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyocera Corp filed Critical Kyocera Corp
Priority to JP3343435A priority Critical patent/JP3064077B2/en
Publication of JPH05168693A publication Critical patent/JPH05168693A/en
Application granted granted Critical
Publication of JP3064077B2 publication Critical patent/JP3064077B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は疾病、災害などにより、
骨機能や手足の関節機能が失われた場合、これらを修復
するために用いられる整形外科用人工骨及び人工関節、
あるいは老齢、疾病などによって失われた歯牙を再建す
るために用いられる人工歯根等を構成する生体に埋設す
る複合インプラント部材に関するものである。
BACKGROUND OF THE INVENTION The present invention relates to diseases, disasters, etc.
Orthopedic artificial bones and joints used to repair bone and limb joint functions when they are lost,
Alternatively, the present invention relates to a composite implant member embedded in a living body constituting an artificial tooth root or the like used for reconstructing a tooth lost due to aging, disease, or the like.

【0002】[0002]

【従来の技術】すでに臨床使用されているチタン材とジ
ルコニアセラミックスを組み合わせた複合インプラント
部材としては、例えば骨内に埋入するインプラントとし
てジルコニアボールとチタンステムをテーパーで嵌合さ
せた人工股関節がある。これは生体内で優れた摺動特性
と強度を示すジルコニアボールと優れた靱性、強度およ
び耐蝕性を有するチタンステムを一体化したものであ
る。又、整形外科領域においては、上記の人工股関節以
外にも、人工膝関節、足関節、肩関節、手関節などにジ
ルコニアを主成分とするジルコニアセラミックスとチタ
ン又はチタン合金より成るチタン材を接合したインプラ
ントの応用がある。
2. Description of the Related Art As a composite implant member combining a titanium material and zirconia ceramics which has already been clinically used, for example, there is an artificial hip joint in which a zirconia ball and a titanium stem are fitted with a taper as an implant to be implanted in bone. . This is obtained by integrating a zirconia ball having excellent sliding characteristics and strength in a living body with a titanium stem having excellent toughness, strength and corrosion resistance. In addition, in the orthopedic field, in addition to the above-mentioned artificial hip joints, artificial titanium joints, ankle joints, shoulder joints, hand joints and the like are joined with zirconia ceramics containing zirconia as a main component and a titanium material made of titanium or a titanium alloy. There are implant applications.

【0003】さらに、歯科領域においては骨内埋入型イ
ンプラントへの応用が考えられている。現在、サファイ
アの芯材にポーラス状のアルミナをガラスでもって接合
したポーラス状アルミナが骨に接するように構成したイ
ンプラントが使われているが、芯部がサファイアである
ため強度上の問題があった。この点を改良するためチタ
ン材の芯材に対してポーラス状のジルコニアセラミック
スを接合して複合化したインプラントの開発が期待され
ている。
[0003] Further, in the dental field, application to an implant implantable in bone has been considered. Currently, implants are used in which porous alumina is bonded to bone with porous alumina bonded to sapphire core material with glass, but there was a problem in strength because the core was sapphire . In order to improve this point, development of an implant in which porous zirconia ceramics are bonded to a titanium core material to form a composite is expected.

【0004】従来、インプラントにおけるチタン材とジ
ルコニアセラミックスとを複合化するにはチタン材の表
面に溶射法、CVD法、PVD法、陽極酸化法などによ
ってジルコニアをコーティングする方法や、チタン材と
ジルコニアセラミックスがともにバルク状であるときに
は活性金属法によって接合していた。これはチタン材と
ジルコニアセラミックスの界面にTi−Al−Cu合金
などのペーストを塗り、両者を突き合わせて加熱し接合
する方法で、比較的強固な接合が得られていた。
Conventionally, a titanium material and a zirconia ceramic have been combined in an implant by coating the surface of the titanium material with zirconia by a spraying method, a CVD method, a PVD method, an anodic oxidation method, or the like, When both were in bulk, they were joined by the active metal method. This is a method in which a paste of a Ti-Al-Cu alloy or the like is applied to the interface between the titanium material and the zirconia ceramics, and the two are abutted and heated for joining, whereby a relatively strong joint has been obtained.

【0005】[0005]

【従来技術の課題】しかしながら、CVD法、PVD
法、陽極酸化法などによって作製したジルコニアのコー
ティング層は数千オングストロングから10μm 程度の
厚みしか有せずコーティング層に耐久性がなかった。一
方、溶射法によれば数十〜数百μm の厚みにすることが
できるが、この方法の場合母材であるチタン材の表面の
微小な凹凸によるアンカー効果にのみ依存しているため
強度に問題がある。
2. Description of the Related Art However, CVD, PVD
The zirconia coating layer produced by the method or the anodic oxidation method had a thickness of only several thousand angstroms to about 10 μm, and the coating layer had no durability. On the other hand, according to the thermal spraying method, the thickness can be reduced to several tens to several hundreds of μm.However, in this method, the strength depends on only the anchor effect due to minute irregularities on the surface of the titanium material as the base material, so that the strength is low. There's a problem.

【0006】また活性金属法により製作した複合インプ
ラント部材の場合、界面でのチタンと接合のために用い
られるロー材に含まれる金属との間で、激しいガルバニ
ックコロージョンが起こり、特に生体内の如く水分の多
い環境には適さないという不具合があった。
In the case of a composite implant member manufactured by the active metal method, intense galvanic corrosion occurs between titanium at the interface and the metal contained in the brazing material used for bonding, and in particular, moisture such as in a living body. There was a problem that it was not suitable for an environment with many.

【0007】[0007]

【課題を解決するための手段】上記の課題を解決するた
め、本発明は純チタンまたはチタン合金よりなるチタン
材とジルコニアを主成分とするジルコニアセラミックス
とを、SiO2 を60〜80wt%、BaOを5〜15
wt%、K2 Oを〜12wt%,Na2 Oを5〜12
wt%及びZnOを0〜7wt%含むガラスでもって接
合し、一体化してなる複合インプラント部材を提供する
ものである。
To solve the above problems SUMMARY OF THE INVENTION The present invention provides a zirconia ceramic mainly comprising titanium material and zirconia consisting of pure titanium or a titanium alloy, a SiO 2 60~80wt%, BaO 5 to 15
wt%, a K 2 O 5 ~12wt%, a Na 2 O. 5 to 12
The present invention provides a composite implant member which is bonded and integrated with glass containing 0 to 7 wt% of ZnO and 0 to 7 wt%.

【0008】[0008]

【実施例】以下、本発明の実施例を図を用いて詳述す
る。チタン材とジルコニアセラミックスは熱膨張係数が
両者ともに10×10-6/deg前後でほぼ等しいため
同様な熱膨張係数を持つ生体ガラスを介して接合すれば
オートクレープ滅菌、ガス滅菌の際に加熱される事があ
ってもこれによって純チタンまたはチタン合金よりなる
チタン材とジルコニアを主成分とするジルコニアセラミ
ックスとを組み合わせた複合インプラント部材のチタン
材とジルコニアセラミックスの接合面の損傷、ジルコニ
アセラミックスでのクラックの発生などを起こすことな
い生体材料を構成できることを知見した。
DESCRIPTION OF THE PREFERRED EMBODIMENTS Embodiments of the present invention will be described below in detail with reference to the drawings. Since both the titanium material and the zirconia ceramic have approximately the same coefficient of thermal expansion at around 10 × 10 −6 / deg, they are heated during autoclave sterilization and gas sterilization if they are joined via living glass having a similar coefficient of thermal expansion. This may cause damage to the joint surface between the titanium material and the zirconia ceramic of the composite implant member that combines the titanium material made of pure titanium or titanium alloy and the zirconia ceramic mainly composed of zirconia, and cracks in the zirconia ceramic. It has been found that a biomaterial that does not cause the generation of a biomaterial can be constructed.

【0009】そこで、まず図1に示すようなAlを6w
t%とVを4wt%含むチタン合金よりなる直径25m
m、高さ60mmの円柱体であるチタン材2を40個と
直径25mm、高さ60mmの円柱体でありジルコニア
を主成分としY2 3 を4.5wt%含むジルコニアセ
ラミックス3を40個作製した。続いて、SiO2 を7
0wt%、BaOを10wt%、K2 Oを8wt%、N
2 Oを7wt%及びZnOを5wt%含み、平均粒径
が100μmのガラス粉末を調整し、これにエタノール
を加えペースト状にした。そしてペースト状のガラス粉
末をそれぞれ20個の上記チタン材2とジルコニアセラ
ミックス3の直径25mmの円状の端面2a、3aの一
方に塗布して、一組づつ両者を突き合わせた後、周囲を
チタン合金よりなる治具でずれないように固定した。さ
らにこれらを最高温度800℃、真空度10-3torr
の条件下、熱処理を施してガラス4を軟化させた後、自
然冷却して図2に示すようなチタンまたはチタン合金よ
りなるチタン材2とジルコニアを主成分とするジルコニ
アセラミックス3を厚さ60μmのガラス4で接合して
なる本発明の複合インプラント部材1を20個作製し
た。
Therefore, first, as shown in FIG.
25m in diameter made of a titanium alloy containing 4% by weight of t% and V
m, 40 pieces of titanium material 2 having a height of 60 mm and 40 pieces of zirconia ceramics 3 having a diameter of 25 mm and a height of 60 mm, containing zirconia as a main component and containing 4.5 wt% of Y 2 O 3. did. Subsequently, 7 of SiO 2
0 wt%, BaO 10 wt%, K 2 O 8 wt% , N
A glass powder containing 7 wt% of a 2 O and 5 wt% of ZnO and having an average particle diameter of 100 μm was prepared, and ethanol was added thereto to form a paste. Then, the paste-like glass powder is applied to one of the 20 end faces 2a, 3a having a diameter of 25 mm of the titanium material 2 and the zirconia ceramics 3 each of 20 pieces, and the two are abutted one by one. It was fixed so that it did not slip with a jig. Further, these are subjected to a maximum temperature of 800 ° C. and a degree of vacuum of 10 −3 torr.
After softening the glass 4 by heat treatment under the conditions described above, the glass 4 is naturally cooled and a titanium material 2 made of titanium or a titanium alloy and a zirconia ceramics 3 containing zirconia as a main component as shown in FIG. Twenty composite implant members 1 of the present invention joined by glass 4 were produced.

【0010】比較の為、上記チタン材2とジルコニアセ
ラミックス3をそれぞれ残りの20個づつに活性金属ロ
ーを塗布し、活性金属法により試験片一組づつ接合して
実施例と同様の20個の比較試験体を作製した。
For comparison, the titanium material 2 and the zirconia ceramics 3 were each coated with an active metal braze on the remaining 20 pieces and joined together by a test piece by the active metal method. A comparative specimen was prepared.

【0011】次に、上記の20個のうち15個の複合イ
ンプラント部材1と20個のうち15個の比較試験体を
37℃のリンゲル液中に浸漬して3、6、12カ月ごと
に両者からそれぞれ5個つつ取り出し長軸方向への引張
試験を行い円柱片の界面での破壊強度をはかり5個の平
均値を接合強度とした。また、残りの5個については浸
漬せずに上記の方法で破壊強度を測定した。この結果を
表1に示す。
Next, fifteen of the twenty composite implant members 1 and fifteen of the twenty comparative test specimens were immersed in Ringer's solution at 37 ° C., and were immersed every 3, 6, 12 months. Ten pieces were taken out of each piece, a tensile test was performed in the major axis direction, and the breaking strength at the interface of the cylindrical pieces was measured. The remaining five pieces were measured for breaking strength by the above method without immersion. Table 1 shows the results.

【0012】[0012]

【表1】 [Table 1]

【0013】表1より明らかなように本発明の複合イン
プラント部材1では12か月を経過しても接合強度がほ
とんど変化していない。一方、活性金属法を用いて作製
した比較試験体においては3ヵ月で接合強度は約1/4
に低下し、6ヵ月では接合が解消され接合強度0の状態
になってしまった。また3ヵ月目ですでにロウ材部分に
激しい腐食が見られ、浸漬液は著しく濁っていた。
As is clear from Table 1, the bonding strength of the composite implant member 1 of the present invention hardly changes even after 12 months. On the other hand, in the comparative specimen prepared using the active metal method, the bonding strength was about 1/4 in 3 months.
After 6 months, the bonding was canceled and the bonding strength became zero. In the third month, severe corrosion was already observed in the brazing material, and the immersion liquid was extremely turbid.

【0014】次に、直径25mm、高さ60mmの円柱
体でありジルコニアを主成分としY2 3 を2.5wt
%含むジルコニアセラミックス3と同寸法の円柱体であ
りY2 3 を6.5wt%及びAl2 3 を20wt%
含有するジルコニア3を各一個づつとAlを6wt%と
Vを4wt%含むチタン合金よりなり、直径25mm、
高さ60mmの円柱体であるチタン材2を2個作製し、
続いて前述の方法で図2に示すような、前記の組成でな
る厚さ50μm の厚さのガラス4でチタン材とジルコニ
アセラミックス3を接合してなる2種類の複合インプラ
ント部材1を作製し上述の浸漬実験と同様な実験を行な
ったが、前記の複合インプラント部材1とほぼ同じ結果
が得られた。これは、チタン材2やジルコニアセラミッ
クス3は組成が変わっても熱膨張係数が変化しないため
であるためと知見した。
Next, a cylindrical body having a diameter of 25 mm and a height of 60 mm, containing zirconia as a main component and adding Y 2 O 3 of 2.5 wt.
% Zirconia ceramic 3 including a cylindrical body having the same dimensions Y 2 O 3 and 6.5 wt% and Al 2 O 3 of 20 wt%
It is made of a titanium alloy containing 6 wt% of Al and 4 wt% of V, each having a zirconia 3 content of 25 mm in diameter,
Two titanium materials 2 each of which is a cylindrical body having a height of 60 mm are produced,
Subsequently, as shown in FIG. 2, two kinds of composite implant members 1 were prepared by joining a titanium material and zirconia ceramics 3 with a glass 4 having a thickness of 50 μm and a thickness of 50 μm. An experiment similar to the above immersion experiment was performed, but almost the same result as that of the composite implant member 1 was obtained. This is because the thermal expansion coefficient of the titanium material 2 and the zirconia ceramic 3 does not change even if the composition changes.

【0015】次に本発明の構成要素であるガラスの有効
組成を限定する為以下に説明するような実験を行なっ
た。図1に示すような、Alを6wt%とVを4wt%
含むチタン合金よりなる直径25mm、高さ60mmの
円柱体であるチタン材2を14個と直径25mm、高さ
60mmの円柱体でありジルコニアを主成分としY2
3 を4.5wt%含むジルコニアセラミックス3を14
個作製した。続いて表2のA〜Gの組成よりなり、平均
粒径が100μm のガラス粉末を調整し、それぞれにエ
タノールを加えぺースト状にした。そしてそれぞれのペ
ースト状のガラス粉末を前記チタン材2とジルコニアセ
ラミックス3の直径25mmの円状の端面2a、3aの
一方に塗布して、一組づつ両者を突き合わせた後、周囲
をチタン合金よるなる治具でずれないように固定した。
さらにこれらを最高温度800℃、真空度10-3tor
rの条件下熱処理を施してガラスを軟化させた後、自然
冷却して、図2に示すようなチタンまたはチタン合金よ
りなるチタン材2とジルコニアを主成分とするジルコニ
アセラミックス3を厚さ50μm のガラス4で接合して
なる本発明の複合インプラント部材1をA〜Gの各ガラ
ス成分につきそれぞれ2個づつ合計14個作製した。
Next, in order to limit the effective composition of glass which is a component of the present invention, an experiment as described below was conducted. As shown in FIG. 1, 6 wt% of Al and 4 wt% of V
14 titanium materials 2 each having a diameter of 25 mm and a height of 60 mm made of a titanium alloy containing titanium alloy, and a cylindrical body having a diameter of 25 mm and a height of 60 mm, containing zirconia as a main component and Y 2 O
3 Zirconia Ceramics 3 containing 4.5 wt% of the 14
This was produced. Subsequently, glass powders having the compositions of A to G in Table 2 and having an average particle diameter of 100 μm were prepared, and ethanol was added to each to form a paste. Then, each paste-like glass powder is applied to one of the circular end faces 2a, 3a having a diameter of 25 mm of the titanium material 2 and the zirconia ceramics 3, and the two are abutted one by one. It was fixed with a jig so that it would not slip.
Further, these are heated to a maximum temperature of 800 ° C. and a degree of vacuum of 10 −3 torr.
After softening the glass by heat treatment under the condition of r, the glass is naturally cooled, and a titanium material 2 made of titanium or a titanium alloy and a zirconia ceramics 3 containing zirconia as a main component as shown in FIG. A total of 14 composite implant members 1 of the present invention joined by the glass 4 were produced, two for each of the glass components A to G.

【0016】[0016]

【表2】 [Table 2]

【0017】これらの複合インプラント部材1のうち成
分の異なるA〜Gの組成のガラスを用いたもの1個づ
つ、計7個につき長軸方向への引張試験を行い円柱片の
界面での破壊強度をはかりその値を接合強度とした。ま
た残りの7個を70℃の生理食塩水中へ浸漬して90日
経過させ同様に接合強度を求めた。その結果を表2に示
す。
[0017] Tensile tests were performed in the long axis direction for each of the composite implant members 1 using glass having different compositions of A to G, and the fracture strength at the interface of the cylindrical pieces was measured. The value was taken as the bonding strength. The remaining seven were immersed in a physiological saline solution at 70 ° C. for 90 days, and the bonding strength was determined in the same manner. Table 2 shows the results.

【0018】表2から明らかなようにガラスB、C、
D、E、Fを用いたものについては90日経過しても接
合強度が2800kgf以上であり、また浸漬による強
度低下がほとんど認められなかった。
As is clear from Table 2, glasses B, C,
For those using D, E, and F, the bonding strength was 2800 kgf or more even after 90 days, and almost no decrease in strength due to immersion was observed.

【0019】接合強度2800kgfは、単位面積当た
りの強度に換算すると約570kgf/cm2 であり成
人ヒトの界面骨の引張強度が107kgf/cm2 と報
告されているが(山本 真、笹田 直監訳「整形外科バ
イオメカニクス入門」、第27頁)、その値の約5.2
倍でありインプラントの引張強度としては十分である。
The bonding strength of 2800 kgf is approximately 570 kgf / cm 2 when converted into the strength per unit area, and the tensile strength of the interface bone of an adult human is reported to be 107 kgf / cm 2. Introduction to Orthopedic Biomechanics ”, p. 27), about 5.2 of that value.
This is double the tensile strength of the implant.

【0020】したがって好ましいガラスはSiO2 を6
0〜80wt%、BaOを5〜15wt%、K2 Oを
〜12wt%,Na2 Oを5〜12wt%及びZnOを
0〜7wt%含むものである。
Therefore, the preferred glass is SiO 2
0~80wt%, 5~15wt% of BaO, and K 2 O 5
~12wt%, in which a. 5 to 12 wt% and ZnO of Na 2 O containing 0~7wt%.

【0021】次に、図3に示すように純チタンより成る
直径2.5mm、高さが7mmの円柱体であるチタン材
2と外径が4.0mm、軸線方向に設けられた貫通孔2
aの孔径が2.7mm、高さ7mmのポーラスジルコニ
アよりなる円筒体(気孔率30%、細孔率100〜20
0μm)であるジルコニアセラミックス3を作製した。
続いて、SiO2 を70wt%、BaOを10wt%、
2 Oを8wt%、Na 2 Oを7wt%及びZnOを5
wt%含み、平均粒径が30μmのガラス粉末を調整
し、これにエタノールを加えペースト状にした。そして
ペースト状のガラス粉末を上記チタン材2の曲面を成す
側面2bに塗布し、これを上記アルミナセラミックス3
の貫通孔3b内に挿入し、さらに、これをArガス雰囲
気中、最高温度1200℃の条件下、熱処理を施してガ
ラス4を軟化させた後、自然冷却して図4に示すような
チタンまたはチタン合金よりなるチタン材2とジルコニ
アを主成分とするジルコニアセラミックス3を厚さ2m
mのガラス4で接合してなる本発明の複合インプラント
部材1を3個作製した。
Next, as shown in FIG. 3, a titanium material 2 made of pure titanium and having a diameter of 2.5 mm and a height of 7 mm, and a through hole 2 having an outer diameter of 4.0 mm and provided in the axial direction.
A cylindrical body made of porous zirconia having a pore diameter of 2.7 mm and a height of 7 mm (porosity 30%, porosity 100 to 20)
Zirconia ceramics 3 having a thickness of 0 μm).
Subsequently, 70 wt% of SiO 2 , 10 wt% of BaO,
8 wt% of K 2 O, 7 wt% of Na 2 O, and 5 of ZnO
A glass powder containing 30% by weight and having an average particle diameter of 30% by weight was prepared, and ethanol was added thereto to form a paste. Then, a paste-like glass powder is applied to the curved side surface 2 b of the titanium material 2, and this is applied to the alumina ceramic 3.
And then heat-treated in an Ar gas atmosphere at a maximum temperature of 1200 ° C. to soften the glass 4 and then naturally cooled to form titanium or titanium as shown in FIG. A titanium material 2 made of a titanium alloy and a zirconia ceramic 3 containing zirconia as a main component are 2 m thick.
Three composite implant members 1 of the present invention, which were joined with the glass 4 of m, were manufactured.

【0022】また、並行して直径4.0mm、高さ7m
mのポーラスジルコニアより成る円柱体であって、気孔
率30%、細孔径100〜200μm の比較試験体を3
個作製した。
In parallel, the diameter is 4.0 mm and the height is 7 m.
m of porous zirconia having a porosity of 30% and a pore diameter of 100 to 200 μm.
This was produced.

【0023】上述のように作製した複合インプラント部
材1と比較試験体をオートクレーブ滅菌処理した後、そ
れぞれウサギの脛骨骨髄内に埋入し、3ヵ月目、6ヵ月
目、12ヵ月目に屠殺し、摘出した複合インプラント部
材1と比較試験体と周囲組織を検索した。その結果、3
ヵ月目、6ヵ月目、12ヵ月目いずれの場合でも複合イ
ンプラント部材1と比較試験体との間に顕著な差は認め
られず、6カ月目にはすでに両者ともに骨組織がポーラ
ス状のジルコニアセラミックス3の側面から700μm
の深さまで侵入し、強固に骨内に固定されていた。また
複合インプラント部材1のガラスの損傷、破壊やポーラ
ス状のジルコニアセラミックス3でのクラックの発生等
も一切なかった。
After the composite implant member 1 and the comparative specimen prepared as described above were subjected to autoclave sterilization treatment, they were respectively implanted into the bone marrow of the tibia of a rabbit, and sacrificed at 3, 6, and 12 months. The extracted composite implant member 1, the comparative specimen and the surrounding tissue were searched. As a result, 3
No significant difference was observed between the composite implant member 1 and the comparative specimen at any of the six months, the sixth month and the twelfth month. By the sixth month, both had already had porous zirconia ceramics with a porous bone structure. 700 μm from the side of 3
Penetrated to the depth of the bone and was firmly fixed in the bone. In addition, there was no damage or destruction of the glass of the composite implant member 1 or cracks generated in the porous zirconia ceramics 3.

【0024】これは、接合に用いるガラス4が生体内で
周囲組織に何等悪影響を与えものではなく生体内で安定
的な状態にあることを示している。
This indicates that the glass 4 used for bonding has no adverse effect on the surrounding tissue in the living body and is in a stable state in the living body.

【0025】なお、ガラス4の厚みとしては3μm 〜3
mmが好ましく、3μm よる薄ければガラス4をムラな
く塗布することが不可能となり、3mmを超えては強度
が不十分となる。強度の点からガラス4の最も好ましい
厚みは50〜600μm 程度である。
The thickness of the glass 4 is 3 μm to 3 μm.
mm is preferable, and if it is thinner than 3 μm, it is impossible to apply the glass 4 without unevenness, and if it exceeds 3 mm, the strength becomes insufficient. From the viewpoint of strength, the most preferable thickness of the glass 4 is about 50 to 600 μm.

【0026】図5〜図9は本発明の複合インプラント部
材の応用例を示すもので2はチタンまたはチタン合金よ
りなるチタン材、3はジルコニアを主成分とするジルコ
ニアセラミックス、4はガラスを示す。
5 to 9 show application examples of the composite implant member of the present invention. Reference numeral 2 denotes a titanium material made of titanium or a titanium alloy, 3 denotes a zirconia ceramic containing zirconia as a main component, and 4 denotes glass.

【0027】図5において10はスクリュー型の人工歯
根である複合インプラント部材であり、スクリュー部1
1はチタン合金の母材であるチタン材2の周囲にスクリ
ュー状の外表面形状を有するポーラスジルコニアより成
るジルコニアセラミックス3がガラス4でもって接合し
てある。このようなスクリュー部11は強度にも優れ、
また優れた骨誘導能を示した。
In FIG. 5, reference numeral 10 denotes a composite implant member which is a screw-type artificial tooth root.
Reference numeral 1 denotes a zirconia ceramic 3 made of porous zirconia having a screw-shaped outer surface formed by bonding a glass 4 around a titanium material 2 which is a base material of a titanium alloy. Such a screw portion 11 has excellent strength,
It also showed excellent osteoinductive ability.

【0028】また図6及び図7において20は人工膝関
節の大腿骨部材である複合インプラント部材であって、
本体を成すチタン合金より成るチタン材2の低部の摺動
面部21,21にはガラス4でもって緻密質ジルコニア
セラッミクよる成るジルコニアセラミックス3を接合せ
しめてある。このような摺動面部21は良好な強度、摺
動特性を示した。
6 and 7, reference numeral 20 denotes a composite implant member which is a femoral member of an artificial knee joint.
A zirconia ceramic 3 made of dense zirconia ceramic is bonded to a lower sliding surface portion 21, 21 of a titanium material 2 made of a titanium alloy constituting a main body with a glass 4. Such a sliding surface portion 21 exhibited good strength and sliding characteristics.

【0029】また図8及び図9において、30は人工股
関節のステム部材である複合インプラント部材であり、
ジルコニアビーズ部31は本体であり、チタン合金より
成るチタン部材2と、別途作製したジルコニアビーズの
結合体であるジルコニア部材3をガラス3でもって接合
してある。このようなジルコニアビーズ部31は優秀な
強度と良好な骨誘導能を示した。
8 and 9, reference numeral 30 denotes a composite implant member which is a stem member of an artificial hip joint.
The zirconia bead part 31 is a main body, and a titanium member 2 made of a titanium alloy and a zirconia member 3 which is a combined body of separately produced zirconia beads are bonded with glass 3. Such zirconia bead portions 31 exhibited excellent strength and good osteoinductive ability.

【0030】[0030]

【発明の効果】本発明の複合インプラント部材は生体内
での長期間の使用によっても接合強度の低下が少なく、
また生体に悪影響を与えることがない。
According to the composite implant member of the present invention, a decrease in bonding strength is small even after long-term use in a living body.
Also, there is no adverse effect on the living body.

【図面の簡単な説明】[Brief description of the drawings]

【図1】チタン材とジルコニアセラミックスを示す斜視
図である。
FIG. 1 is a perspective view showing a titanium material and zirconia ceramics.

【図2】本発明の複合インプラントを示す斜視図であ
る。
FIG. 2 is a perspective view showing a composite implant of the present invention.

【図3】チタン材とジルコニアセラミックスを示す斜視
図である。
FIG. 3 is a perspective view showing a titanium material and zirconia ceramics.

【図4】本発明の複合インプラントを示す斜視図であ
る。
FIG. 4 is a perspective view showing a composite implant of the present invention.

【図5】本発明の複合インプラント部材の人工歯根への
応用を示す部分断面側面図である。
FIG. 5 is a partial cross-sectional side view showing the application of the composite implant member of the present invention to an artificial dental root.

【図6】本発明の複合インプラント部材の人工膝関節の
脛骨部材への応用を示す正面図である。
FIG. 6 is a front view showing the application of the composite implant member of the present invention to a tibial member of an artificial knee joint.

【図7】図6のA−A線断面図である。FIG. 7 is a sectional view taken along line AA of FIG. 6;

【図8】本発明の複合インプラント部材の人工股関節ス
テム部材への応用を示す側面図である。
FIG. 8 is a side view showing the application of the composite implant member of the present invention to an artificial hip joint stem member.

【図9】図8のB−B線断面図である。FIG. 9 is a sectional view taken along line BB of FIG. 8;

【符号の説明】[Explanation of symbols]

2 チタン材 3 ジルコニアセラミックス 4 ガラス 1,10,20,30 複合インプラント部材 2 titanium material 3 zirconia ceramics 4 glass 1,10,20,30 composite implant member

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI A61F 2/30 A61F 2/30 C03C 8/04 C03C 8/04 C04B 37/02 C04B 37/02 A ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification code FI A61F 2/30 A61F 2/30 C03C 8/04 C03C 8/04 C04B 37/02 C04B 37/02 A

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】純チタンまたはチタン合金よりなるチタン
材とジルコニアを主成分とするジルコニアセラミックス
とを、SiO2 を60〜80wt%、BaOを5〜15
wt%、K2 Oを〜12wt%,Na2 Oを5〜12
wt%及びZnOを0〜7wt%含むガラスでもって接
合し、一体化してなる複合インプラント部材。
The zirconia ceramic mainly composed of 1. A titanium material and zirconia consisting of pure titanium or a titanium alloy, a SiO 2 60~80wt%, the BaO 5 to 15
wt%, a K 2 O 5 ~12wt%, a Na 2 O. 5 to 12
A composite implant member joined and integrated with glass containing 0% to 7% by weight of ZnO.
JP3343435A 1991-12-25 1991-12-25 Composite implant components Expired - Fee Related JP3064077B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3343435A JP3064077B2 (en) 1991-12-25 1991-12-25 Composite implant components

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3343435A JP3064077B2 (en) 1991-12-25 1991-12-25 Composite implant components

Publications (2)

Publication Number Publication Date
JPH05168693A JPH05168693A (en) 1993-07-02
JP3064077B2 true JP3064077B2 (en) 2000-07-12

Family

ID=18361497

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3343435A Expired - Fee Related JP3064077B2 (en) 1991-12-25 1991-12-25 Composite implant components

Country Status (1)

Country Link
JP (1) JP3064077B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003094193A1 (en) * 2002-05-01 2003-11-13 Sony Corporation Cold cathode electric field electron emission display device

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5487562B2 (en) * 2008-06-05 2014-05-07 セイコーエプソン株式会社 Method for producing dental implant
DE102012002268A1 (en) * 2011-03-21 2012-09-27 Zm Präzisionsdentaltechnik Gmbh Process for producing a structured coating on ceramic implants
DE102015016894B3 (en) * 2015-12-29 2017-07-13 Zm Präzisionsdentaltechnik Gmbh implant
DE102015016895B3 (en) 2015-12-29 2017-05-24 Zm Präzisionsdentaltechnik Gmbh knee replacement
DE102015016893B3 (en) 2015-12-29 2017-07-13 Milija Mitrovic Orthopedic implant

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003094193A1 (en) * 2002-05-01 2003-11-13 Sony Corporation Cold cathode electric field electron emission display device

Also Published As

Publication number Publication date
JPH05168693A (en) 1993-07-02

Similar Documents

Publication Publication Date Title
EP0421987B1 (en) An implant for the replacement of a tooth or a part of the bone tissue
Cook et al. Interface mechanics and histology of titanium and hydroxylapatite-coated titanium for dental implant applications.
JP4091728B2 (en) Bioimplant material and its manufacturing method
Nakamura et al. A new glass‐ceramic for bone replacement: Evaluation of its bonding to bone tissue
Sun et al. Material fundamentals and clinical performance of plasma‐sprayed hydroxyapatite coatings: A review
JPH0332675A (en) Bioimplanting material and production thereof
Wang et al. Interfacial shear strength and histology of plasma sprayed and sintered hydroxyapatite implants in vivo
Driskell et al. Development of ceramic and ceramic composite devices for maxillofacial applications
Hench et al. An investigation of bonding mechanisms at the interface of a prosthetic material
JP3064077B2 (en) Composite implant components
Pajamäki et al. Bioactive glass and glass-ceramic-coated hip endoprosthesis: experimental study in rabbit
JP2883214B2 (en) Biological implant material and its manufacturing method
Bokros New material concepts in orthopedics
JPH05208043A (en) Composite implant
RU2705805C2 (en) Bone implant
JP2984118B2 (en) Biological implant material and its manufacturing method
Klawitter et al. Tissue ingrowth and mechanical locking for anchorage of prostheses in locomotor system
JPH11178912A (en) Organism prosthetic material
JP2997809B2 (en) Biological implant components
JP2931906B2 (en) Ceramics for bioprostheses
Ishikawa et al. Effect of hydroxyapatite containing glass coating on the bonding between bone and titanium implants
Barth et al. Bone fixation of ceramic-coated and fiber titanium implants: A study in weight-bearing rats
JPH08117324A (en) Method for manufacturing a bio-implant material
JPS63160663A (en) Medical member excellent in bone compatibility and its production
JPH0241151A (en) Artificial dental root

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees